Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme

by Jan Hendrik Richardus, ProfPhD, Anuj Tiwari, PhD, Tanja Barth-Jaeggi, PhD, Mohammad A Arif, MD, Nand Lal Banstola, MBA, Rabindra Baskota, MD, David Blaney, MD, David J Blok, PhD, Marc Bonenberger, PhD, Teky Budiawan, MD, Arielle Cavaliero, MPH, Zaahira Gani, MSc, Helena Greter, PhD, Eliane Ignotti, ProfPhD, Deusdedit V Kamara, MD, Christa Kasang, PhD, Pratap R Manglani, MD, Liesbeth Mieras, MD, Blasdus F Njako, MD, Tiara Pakasi, MA, Basu Dev Pandey, PhD, Paul Saunderson, PhD, Rajbir Singh, MD, W Cairns S Smith, ProfPhD, René Stäheli, MSc, Nayani D Suriyarachchi, MD, Aye Tin Maung, MD, Tin Shwe, MD, Jan van Berkel, MA, Wim H van Brakel, PhD, Bart Vander Plaetse, MD, Marcos Virmond, ProfPhD, Millawage S D Wijesinghe, MD, Ann Aerts, MD, Peter Steinmann, PhD
Published 2021-01-01